Leading allergy organizations release report that sheds light on angioedema

Published on November 9, 2012 at 5:11 AM · No Comments

With today's modern medicine, misdiagnoses may be unexpected and surprising. But when symptoms of an unknown and uncommon illness mimic a number of other conditions, it can be difficult for medical professionals to properly diagnose and treat patients. That's why four leading allergy/immunology organizations have announced the release of a report to help set a new standard for a commonly misdiagnosed, under-recognized and under treated condition known as angioedema, the rapid swelling of deep layers of skin and tissue.

This report, titled International Consensus (ICON) on Hereditary and Acquired Angioedema, was released today during the Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Anaheim, Calif. It is the latest ICON from the International Collaboration in Asthma, Allergy and Immunology (iCAALL), a joint project of the ACAAI, the American Academy of Allergy, Asthma & Immunology (AAAAI), the European Academy of Allergy and Clinical Immunology (EAACI) and the World Allergy Organization (WAO).

"There is an international lack of understanding, consensus-driven information and general recommendations for angioedema," said David M. Lang, M.D., chair of the ICON Hereditary and Acquired Angioedema and ACAAI Fellow. "This ICON report will help ensure the proper diagnosis and management of hereditary and acquired angioedema, while helping patients with these conditions find relief and live healthy, active lifestyles."

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post